©
2013 City of Hope
1500 East Duarte Road
Duarte, CA 91010
626-256-HOPE (4673)
1500 East Duarte Road
Duarte, CA 91010
626-256-HOPE (4673)
A National Cancer Institute-designated Comprehensive Cancer Center
388px
Cancer Genetics Education Program
Cancer Genetics Education Program
The
Division of Clinical Cancer Genetics
at City of Hope offers educational coursesand self-teaching tools forprofessionals in the fields of cancer and cancer genetics.ThisCancer Genetics Education Program (CGEP) is supported inpart by funding fromthe NCI (IRC4CA153828-01 andIR25CA112486).
Dramatic advances in our understanding of the genetic basis for cancer have led to the development of new technologies and tools for genetic cancer risk assessment. The Cancer Genetics Education Program atCity of Hope offers a series of comprehensive learning tools designed to enhance the education of primary care physicians and clinical oncology professionals on the topics of cancer genetics and cancer risk assessment, and their application to patient care. Through a series of educational courses, workshops, seminars, newsletters and a direct, interactive electronic communications network, professionals can be tutored in the latest information on cancer molecular genetics, the fundamentals of obtaining an adequate family history, understanding genetic cancer risk assessment, ethical and legal complexities of genetic testing, and other current/timely topics.
Cancer Genetics Career Development Program
City of Hope offers an innovative
Cancer Genetics Career Development Program
(CGCDP) whichprovides interdisciplinary training focused on cancer genetics and cancer prevention control research. The Traineeship is open to three applicants per year.
Intensive Course in Cancer Risk Assessment
City of Hope's Division of Clinical Cancer Genetics offers an annual CME/CEU-accredited multi-modal
intensive course
to address the need for professional training in clinical cancer genetics and research collaboration for community-based clinicians.
Clinical Cancer Genetics Community of Practice
City of Hope
Clinical Cancer Genetics Community of Practice
brings cancer genetics practitioners from diverse practice settings together for professional learning, enduring patient-centered support and dynamic community-based research collaborations to promote quality care and improved patient outcomes across the U.S. and internationally.
CCGCRN
Working Group
Clinical Cancer Genetics (CCG) Working Group is a CME-accredited interdisciplinary cancer genetics case conference series conducted each week by the City of Hope clinical team. CSPPN and affiliated clinicians across the U.S. present cases from their community practices via web conferencing for discussion and recommendations on risk assessment, surveillance, risk management and identification of research eligibility for cases covering the full spectrum of hereditary cancer.
Clinical Cancer Genetics Team
The staff of the Division of
Clinical Cancer Genetics
provide genetic counseling and testing through our Cancer Screening & Prevention Program. In addition, they administer the annual Intensive Course in Cancer Risk Assessment, Cancer Genetics Career Development Program, and consult with
City of Hope
physicians and researchers.
Jeffrey N.
Weitzel
, M.D.
Chief
800-826-HOPE (4673) Kathleen Blazer, Ed.D., M.S., L.C.G.C.
Cancer Risk Counselor; Assistant Director, Cancer Genetics Education Program
626-256-8662
kblazer@coh.org Carin Espenschied, M.S., L.C.G.C.
Cancer Risk Counselor
626-256-8662
cespenschied@coh.org Bita Nehoray, M.S., L.C.G.C.
Cancer Risk Counselor
626-256-8662
bnehoray@coh.org Jennifer Siettmann, M.S., G.C.
Genetic Counselor
602-839-6385
Jennifer.Siettmann@bannerhealth.com Jeffrey N. Weitzel, M.D.
Director
800-826-HOPE (4673) Kathleen Blazer, Ed.D., M.S., L.C.G.C.
Assistant Director
626-256-8662
kblazer@coh.org
Chief
800-826-HOPE (4673) Kathleen Blazer, Ed.D., M.S., L.C.G.C.
Cancer Risk Counselor; Assistant Director, Cancer Genetics Education Program
626-256-8662
kblazer@coh.org Carin Espenschied, M.S., L.C.G.C.
Cancer Risk Counselor
626-256-8662
cespenschied@coh.org Bita Nehoray, M.S., L.C.G.C.
Cancer Risk Counselor
626-256-8662
bnehoray@coh.org Jennifer Siettmann, M.S., G.C.
Genetic Counselor
602-839-6385
Jennifer.Siettmann@bannerhealth.com Jeffrey N. Weitzel, M.D.
Director
800-826-HOPE (4673) Kathleen Blazer, Ed.D., M.S., L.C.G.C.
Assistant Director
626-256-8662
kblazer@coh.org
Clinical Cancer Genetics Community of Practice
City of Hope
Clinical Cancer Genetics
Community of Practice brings cancer genetics practitioners from diverse practice settings together for professional learning, enduring patient-centered support and dynamic community-based research collaborations to promote quality care and improved patient outcomes across the U.S. and internationally.Working Group Working Group Clinical Cancer Genetics (CCG) Working Group is a CME-accredited interdisciplinary cancer genetics case conference series conducted each week by the City of Hope clinical team. TICGR Topics in Cancer Genetics Research Topics in Clinical Cancer Genetics (TICGR) is a weekly one-hour CME-accredited web-conference seminar series focused on timely issues in clinical cancer genetics, cancer epidemiology and cancer genetics research, alternating between didactic lectures, case-based literature reviews and basic research journal club.
Genetics Community Link Cancer Genetics Community Link The Cancer Genetics Community Link is a Web-based discussion board for collaborative, interdisciplinary practice-based support and continuing professional learning.
Knowledge Center Knowledge Center Information coming soon
Research Cancer Genetics Community Research Network The Clinical Cancer Genetics Community Research Network (CCGCRN) is a large research group of 32 collaborating sites in the United States and Mexico. As members of the CCGCRN, research collaborators can use the message board and forums to post questions and communicate with other members in the network.
Cancer Genetics Community Link
Case Consultation Questions
Breast/Ovarian Cancers (Uninformative BRCA Test Results)
Breast/Ovarian Cancers (Testing)
Breast/Ovarian Cancers (Probability/Empiric Risks)
Breast/Ovarian Cancers (Risk Management)
Breast/Ovarian Cancers (Hormone Replacement Therapy)
Gastrointestinal Cancers (Lynch Related)
Gastrointestinal Cancers (Polyposis Syndromes)
Gastrointestinal Cancers (Non-Colorectal)
Gastrointestinal Cancers (Risk Management)
ELSI-Ethical, Legal, Social Issues
Clinical Resources
Progeny/Pedigree Drawing Issues
Clinical Cancer Genetics Working Group
CCG Working Group Case Conferences
Comments/Suggestions
Clinical Cancer Genetics Educaton Team
People
http://forms.cityofhope.org/directorysearch/
/physician-bio
Professional Education Options
With state-of-the-art laboratories as classrooms and renowned scientists as teachers and mentors, City of Hope equips the next generation of leaders with skills to transform the future
of medicine.
City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
Local and national conferences, in-depth educational training and a certification program provide both current and aspiring health professionals opportunities to further their knowledge in their fields of interest.
City of Hope offers a range of programs and services, such as Graduate Medical Education and Clinical Training, that serve students, post-doctoral trainees, medical professionals and staff.
Recognized worldwide for its innovative approaches to advancing science, City of Hope offers a number of hands-on fellowships and residencies in an array of areas, from cancer genetics and bone marrow transplantation to surgical oncology and molecular epidemiology.
NEWS & UPDATES
- One in a series of stories asking former patients to reflect upon their experience … Like many who face a cancer diagnosis, Kurt Deetz struggled at first with isolation, fear and depression. Told in 2009 that a malignant lump on his tonsil had spread to a lymph node, he worried about all that he would
- Prostate cancer is the second-leading cause of cancer death among men in the United States, according to the American Cancer Society, and more than 29,000 will die of the disease this year alone. A new City of Hope study suggests those numbers could ultimately be brought down. In findings being presented today...
- Months after hearing the arguments and weeks before concluding its current session, the Supreme Court unanimously ruled that human genes are a product of nature and are not patentable. In the court’s majority opinion, Justice Clarence Thomas wrote: “A naturally occurring DNA segment is a product of...
- As City of Hope celebrates its 100th anniversary, we offer a four-part interview with Art Riggs, Ph.D., chair of the Department of Diabetes and Metabolic Diseases Research. Many of City of Hope’s best-known breakthroughs came through his lab. In this series, he casts an eye back to some of his greatest scientif...
- Patients struggling to overcome blood cancers face a wider threat than just the malignant cells menacing their bodies. They also face challenging — even life-threatening — treatment side effects. For many patients undergoing bone marrow transplantation, graft versus host disease (GVHD) ranks as one of the most ...
- Though endometrial cancer is the most common gynecological cancer, there are no screening tests for the disease and only limited treatments for women whose cancer isn’t eliminated through surgery or radiation. But new City of Hope research could ultimately pave the way both for targeted treatments and screening...
- For breast cancer patients whose disease has spread to local lymph nodes, treatment may entail surgical removal of those nodes to decrease the likelihood of recurrence. But that procedure also comes with the risk of lymphedema, a painful swelling of the arm caused by retained fluids. However, findings from a re...
- Understanding how cells repair DNA damage is key to revealing the role of BRCA1 and other tumor suppressors and to overcoming chemotherapy resistance in cancer. City of Hope research just published in Nucleic Acids Research sheds light on this topic and could lead to improved therapies. Principal investigator ...
- The discovery of genes that may increase a woman’s risk of developing breast cancer has resulted in potentially powerful tools to guide care – but like all new technologies, there’s a learning curve. Many physicians surveyed for a newly released City of Hope study said that, although they feel confident orderin...
- Smita Bhatia has watched pediatric patients defeat cancer, only to see many of them grow into adult survivors confronting new deadly opponents: secondary cancers and serious health problems resulting from the lifesaving but toxic therapies they received as children. Bhatia, M.D., M.P.H., is the Ruth Ziegler Cha...
- Our ability to maintain brain function and preserve learning and memory are at the core of City of Hope research just published in Molecular Cell Biology. Here, lead author Yanhong Shi, Ph.D., an associate professor in the departments of Neurosciences and Radiation Biology, explains the significance of her pape...
- Each year in the United States, lung cancer kills more people than colon, breast and prostate cancers combined. When the least dangerous form of skin cancer is taken out of the equation, lung cancer is the second most-common cancer in both men and women, after prostate and breast cancer respectively. It’s also ...
- As City of Hope celebrates its 100th anniversary, we offer a four-part interview with Art Riggs, Ph.D., chair of the Department of Diabetes and Metabolic Diseases Research. Many of City of Hope’s best-known breakthroughs came through his lab. In this series, he casts an eye back to some of his greatest scientif...
- The importance of applying sunscreen to reduce the risk of skin cancer has been drilled into the public for the past few decades. Yet studies have shown that skin cancer rates continue to climb, with melanoma diagnoses rising nearly 2 percent a year since 2000. What are people doing wrong? Skin cancer expert Vi...
- The first question after a diagnosis of prostate cancer: Is the cancer slow-growing or fast-growing? A slow-growing prostate cancer can simply be monitored, enabling patients to avoid potential side effects of treatment for as long as possible. A fast-growing cancer demands immediate attention, regardless of th...
